Our Story
How can we help the most patients in the shortest time?
For Co-founders Taner Dagdelen and Anthony Joseph, it all started with this question that they first asked on campus at UC Berkeley. 1 in 10 people today have a rare disease. Which means 1 in 10 people have been told that little is known about their disease. Or that their best chance is a promising drug that’s still in development. For every one of these patients, progress can’t come soon enough. Taner and Anthony saw the potential for a massive acceleration of progress, if only they could help each patient unlock the power of their data.
